GULYAKIN, I. (2021) “FEATURES OF THE DEVELOPMENT OF A LYOPHILIZED INJECTABLE DOSAGE FORM OF THE ORIGINAL ANTICANCER DRUG LCS-1208”, International Journal of Applied Pharmaceutics, 13(4), pp. 102–105. doi: 10.22159/ijap.2021v13i4.41371.